A detailed history of Highland Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Highland Capital Management, LLC holds 14,753 shares of OGN stock, worth $215,098. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,753
Previous 16,482 10.49%
Holding current value
$215,098
Previous $341,000 17.3%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$18.65 - $23.03 $32,245 - $39,818
-1,729 Reduced 10.49%
14,753 $282,000
Q2 2024

Jul 25, 2024

SELL
$17.45 - $21.96 $5,810 - $7,312
-333 Reduced 1.98%
16,482 $341,000
Q1 2024

May 07, 2024

SELL
$13.78 - $18.8 $2,824 - $3,854
-205 Reduced 1.2%
16,815 $316,000
Q4 2023

Jan 17, 2024

SELL
$10.95 - $17.32 $44,402 - $70,232
-4,055 Reduced 19.24%
17,020 $245,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $7,183 - $10,292
-433 Reduced 2.01%
21,075 $365,000
Q2 2023

Aug 09, 2023

SELL
$19.27 - $24.63 $30,446 - $38,915
-1,580 Reduced 6.84%
21,508 $447,000
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $21,527 - $32,240
-1,005 Reduced 4.17%
23,088 $543,000
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $36,410 - $44,688
-1,562 Reduced 6.09%
24,093 $673,000
Q3 2022

Nov 09, 2022

SELL
$23.4 - $34.25 $4,492 - $6,576
-192 Reduced 0.74%
25,655 $600,000
Q2 2022

Jul 14, 2022

SELL
$31.66 - $38.9 $4,875 - $5,990
-154 Reduced 0.59%
25,847 $872,000
Q1 2022

Apr 19, 2022

SELL
$30.45 - $39.36 $58,951 - $76,200
-1,936 Reduced 6.93%
26,001 $908,000
Q4 2021

Jan 28, 2022

SELL
$28.67 - $37.13 $60,407 - $78,232
-2,107 Reduced 7.01%
27,937 $851,000
Q3 2021

Oct 25, 2021

SELL
$28.63 - $35.64 $180,454 - $224,638
-6,303 Reduced 17.34%
30,044 $985,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $1.03 Million - $1.38 Million
36,347 New
36,347 $1.1 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.